111 related articles for article (PubMed ID: 1763641)
1. Growth of xenografted head and neck cancer in nude mice pre-treated with whole body irradiation.
Zätterström UK; Wennerberg J
Acta Otolaryngol; 1991; 111(6):1170-7. PubMed ID: 1763641
[TBL] [Abstract][Full Text] [Related]
2. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
[TBL] [Abstract][Full Text] [Related]
3. Histopathological characteristics predictive for growth of squamous cell carcinomas of the head and neck heterotransplanted to nude mice.
Wennerberg J; Willén R; Biörklund A; Tropé C
Anticancer Res; 1986; 6(5):1165-70. PubMed ID: 3800324
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the head and neck heterotransplanted to nude mice. Take rate in relation to patient survival.
Zätterström UK; Wennerberg J; Attewell R; Ask A
Cancer; 1990 Jul; 66(1):145-51. PubMed ID: 2354400
[TBL] [Abstract][Full Text] [Related]
5. The potential of the nude mouse xenograft model for the study of head and neck cancer.
Braakhuis BJ; Sneeuwloper G; Snow GB
Arch Otorhinolaryngol; 1984; 239(1):69-79. PubMed ID: 6691837
[TBL] [Abstract][Full Text] [Related]
6. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
[TBL] [Abstract][Full Text] [Related]
7. Growth characteristics of head and neck squamous cell carcinoma in nude mice.
Elprana D; Kuijpers W; Van den Broek P; Wagener DJ
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1211-22. PubMed ID: 3816913
[TBL] [Abstract][Full Text] [Related]
8. The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft.
Huang P; Taghian A; Allam A; Freeman J; Duffy M; Suit H
Radiat Res; 1996 Mar; 145(3):337-42. PubMed ID: 8927702
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
10. Growth of xenografted squamous cell carcinoma of the head and neck--possible correlation with patient survival.
Zätterström UK; Braakhuis BJ; Wennerberg J; van Dongen GA; Attewell R; Nauta JJ; Laarman DA; Ask A
APMIS; 1992 Nov; 100(11):976-80. PubMed ID: 1472366
[TBL] [Abstract][Full Text] [Related]
11. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
Wennerberg J; Alm P; Lögdberg L; Tropé C
Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Kjellén E; Wennerberg J; Pero R
Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
[TBL] [Abstract][Full Text] [Related]
14. Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts.
Zätterström UK; Engellau J; Johansson MC; Wennerberg J; Kjellén E
Acta Oncol; 1995; 34(2):205-11. PubMed ID: 7718258
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
16. The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts.
Headley DB; Gapany M; Dawson DE; Kruse GD; Robinson RA; McCabe BF
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1269-72. PubMed ID: 1747231
[TBL] [Abstract][Full Text] [Related]
17. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer.
Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ
In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035
[TBL] [Abstract][Full Text] [Related]
18. The nude mouse xenograft system: a model for photodetection and photodynamic therapy in head and neck squamous cell carcinoma.
Hill JH; Plant RL; Harris DM; Grossweiner LI; Rok B; Seter AJ
Am J Otolaryngol; 1986; 7(1):17-27. PubMed ID: 3953966
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
20. An in vivo model for squamous cell carcinoma of the head and neck.
Baker SR
Laryngoscope; 1985 Jan; 95(1):43-56. PubMed ID: 3855324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
